REFERENCES

1. Fallot A. Contribution a l’ anatomie pathologique de la maladie bleue (cyanose cardiaque). Marseille Med 1888;25:418.

2. Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW. Life expectancy without surgery in tetralogy of fallot. Am J Cardiol 1978;42:458-66.

3. Rygg IH, Olesen K, Boesen I. The life history of tetralogy of Fallot. Dan Med Bull 1971;18 Suppl 2:25-30.

4. Al Habib HF, Jacobs JP, Mavroudis C, et al. Contemporary patterns of management of tetralogy of Fallot: data from the Society of Thoracic Surgeons Database. Ann Thorac Surg 2010;90:813-9; discussion 819.

5. Chiu SN, Wang JK, Chen HC, et al. Long-term survival and unnatural deaths of patients with repaired tetralogy of Fallot in an Asian cohort. Circ Cardiovasc Qual Outcomes 2012;5:120-5.

6. Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L. Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 2007;115:163-72.

7. Khairy P, Aboulhosn J, Gurvitz MZ, et al. Alliance for Adult Research in Congenital Cardiology (AARCC). Arrhythmia burden in adults with surgically repaired tetralogy of Fallot: a multi-institutional study. Circulation 2010;122:868-75.

8. Nollert G, Fischlein T, Bouterwek S, et al. Long-term results of total repair of tetralogy of Fallot in adulthood: 35 years follow-up in 104 patients corrected at the age of 18 or older. Thorac Cardiovasc Surg 1997;45:178-81.

9. Prakash A, Powell AJ, Geva T. Multimodality noninvasive imaging for assessment of congenital heart disease. Circ Cardiovasc Imaging 2010;3:112-25.

10. Kilner PJ, Geva T, Kaemmerer H, et al. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J 2010;31:794-805.

11. Geva T. Repaired tetralogy of Fallot: the roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 2011;13:9.

12. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 2019;73:e81-e192.

13. Valente AM, Cook S, Festa P, et al. Multimodality imaging guidelines for patients with repaired tetralogy of Fallot: a report from the American society of echocardiography: developed in collaboration with the society for cardiovascular magnetic resonance and the society for pediatric radiology. J Am Soc Echocardiogr 2014;27:111-41.

14. Egbe AC, Pislaru SV, Kothapalli S, et al. The role of echocardiography for quantitative assessment of right ventricular size and function in adults with repaired tetralogy of Fallot. Congenit Heart Dis 2019;14:700-5.

15. Puchalski MD, Askovich B, Sower CT, et al. Pulmonary regurgitation: determining severity by echocardiography and magnetic resonance imaging. Congenit Heart Dis 2008;3:168-75.

16. Annavajjhala V, Valente AM, Lopez L, et al. Echocardiographic surveillance in children after tetralogy of Fallot repair: adherence to guidelines? Int J Cardiol 2020;307:31-5.

17. Li VW, Yu CK, So EK, Wong WH, Cheung YF. Ventricular myocardial deformation imaging of patients with repaired tetralogy of Fallot. J Am Soc Echocardiogr 2020;33:788-801.

18. Ishizu T, Seo Y, Komatsu Y, Ohte N, Ieda M. 3-dimensional speckle-tracking echocardiography-derived interventricular activation imaging in a patient with repaired tetralogy of Fallot. JACC Case Rep 2020;2:1575-7.

19. Joshi A, Ghadimi Mahani M, Dorfman A, Balasubramanian S. Cardiac MR evaluation of repaired tetralogy of Fallot. Semin Roentgenol 2020;55:290-300.

20. van Straten A, Vliegen HW, Hazekamp MG, et al. Right ventricular function after pulmonary valve replacement in patients with tetralogy of Fallot. Radiology 2004;233:824-9.

21. Vliegen HW, van Straten A, de Roos A, et al. Magnetic resonance imaging to assess the hemodynamic effects of pulmonary valve replacement in adults late after repair of tetralogy of fallot. Circulation 2002;106:1703-7.

22. Simonetti OP, Finn JP, White RD, Laub G, Henry DA. “Black blood” T2-weighted inversion-recovery MR imaging of the heart. Radiology 1996;199:49-57.

23. Poustchi-Amin M, Gutierrez FR, Brown JJ, et al. How to plan and perform a cardiac MR imaging examination. Radiol Clin North Am 2004;42:497-514, v.

24. Pereles FS, Kapoor V, Carr JC, et al. Usefulness of segmented trueFISP cardiac pulse sequence in evaluation of congenital and acquired adult cardiac abnormalities. AJR Am J Roentgenol 2001;177:1155-60.

25. Babu-Narayan SV, Kilner PJ, Li W, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 2006;113:405-13.

26. Wald RM, Haber I, Wald R, et al. Effects of regional dysfunction and late gadolinium enhancement on global right ventricular function and exercise capacity in patients with repaired tetralogy of Fallot. Circulation 2009;119:1370-7.

27. Ghonim S, Gatzoulis MA, Ernst S, et al. Predicting survival in repaired tetralogy of Fallot: a lesion-specific and personalized approach. JACC Cardiovasc Imaging 2022;15:257-68.

28. Firmin DN, Nayler GL, Kilner PJ, Longmore DB. The application of phase shifts in NMR for flow measurement. Magn Reson Med 1990;14:230-41.

29. Mohiaddin RH, Pennell DJ. Mr blood flow measurement. Cardiology Clinics 1998;16:161-87.

30. Fuchs T, Kachelrieß M, Kalender WA. Technical advances in multi-slice spiral CT. Eur J Radiol 2000;36:69-73.

31. Desjardins B, Kazerooni EA. ECG-gated cardiac CT. AJR Am J Roentgenol 2004;182:993-1010.

32. Einstein AJ, Elliston CD, Arai AE, et al. Radiation dose from single-heartbeat coronary CT angiography performed with a 320-detector row volume scanner. Radiology 2010;254:698-706.

33. Nicol ED, Gatzoulis M, Padley SP, Rubens M. Assessment of adult congenital heart disease with multi-detector computed tomography: beyond coronary lumenography. Clin Radiol 2007;62:518-27.

34. Fazel R, Krumholz HM, Wang Y, et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009;361:849-57.

35. Pruckmayer M, Zacherl S, Saizer-Muhar U, Schlemmer M, Leitha T. Scintigraphic assessment of pulmonary and whole-body blood flow patterns after surgical intervention in congenital heart disease. J Nucl Med 1999;40:1477-83.

36. Bourque JM, Beller GA. Stress myocardial perfusion imaging for assessing prognosis: an update. JACC Cardiovasc Imaging 2011;4:1305-19.

37. Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-72.

38. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403-5.

39. McElhinney DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122:507-16.